LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 407 | 4660 | 0.0875 | -0.4405 |
MDA-MB-231 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 344 | 4405 | 0.0776 | -0.5060 |
MDA-MB-231 | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 448 | 4660 | 0.0962 | -0.4119 |
MDA-MB-231 | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 292 | 4405 | 0.0657 | -0.5526 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 72 | hr | 1235 | 454 | 4660 | 0.0971 | -0.4095 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 1235 | 340 | 4405 | 0.0765 | -0.5175 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4661 | 4405 | 1.0586 | 1.0633 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4694 | 4405 | 1.0666 | 1.0721 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 5078 | 4405 | 1.1552 | 1.1644 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 4916 | 4405 | 1.1188 | 1.1268 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 4648 | 4405 | 1.0568 | 1.0618 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 72 | hr | 1235 | 1624 | 4405 | 0.3683 | 0.1566 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4502 | 4660 | 0.9666 | 0.9652 |
MDA-MB-231 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4475 | 4660 | 0.9617 | 0.9604 |
MDA-MB-231 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4053 | 4660 | 0.8712 | 0.8616 |
MDA-MB-231 | Crizotinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2201 | 4660 | 0.4727 | 0.3516 |
MDA-MB-231 | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1421 | 4660 | 0.3055 | 0.0758 |
MDA-MB-231 | Crizotinib | 10 | uM | LJP5 | 72 | hr | 1235 | 939 | 4660 | 0.2016 | -0.1342 |
MDA-MB-231 | BMS345541 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4330 | 4405 | 0.9836 | 0.9824 |
MDA-MB-231 | BMS345541 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3792 | 4405 | 0.8593 | 0.8389 |
MDA-MB-231 | BMS345541 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3687 | 4405 | 0.8374 | 0.8156 |
MDA-MB-231 | BMS345541 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2848 | 4405 | 0.6458 | 0.5744 |
MDA-MB-231 | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 1832 | 4405 | 0.4155 | 0.2380 |
MDA-MB-231 | BMS345541 | 10 | uM | LJP6 | 72 | hr | 1235 | 408 | 4405 | 0.0926 | -0.4547 |
MDA-MB-231 | KIN001-043 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3783 | 4405 | 0.8578 | 0.8381 |